Department of Biomedical and Pharmaceutical Sciences, Chapman University School of Pharmacy, Irvine, California, USA.
Department of Pharmaceutical Sciences, Northeastern University School of Pharmacy, Boston, Massachusetts, USA.
Br J Pharmacol. 2022 Feb;179(3):460-472. doi: 10.1111/bph.15676. Epub 2021 Oct 1.
In the activated state of small-conductance Ca -activated potassium (K 2) channels, calmodulin interacts with the HA/HB helices and the S4-S5 linker. CyPPA potentiates K 2.2a and K 2.3 channel activity but not the K 2.1 and K 3.1 subtypes.
Site-directed mutagenesis, patch-clamp recordings and in silico modelling were utilised to explore the structural determinants for the subtype-selective modulation of K 2 channels by CyPPA.
Mutating residues in the HA (V420) and HB (K467) helices of K 2.2a channels to their equivalent residues in K 3.1 channels diminished the potency of CyPPA. CyPPA elicited prominent responses on mutant K 3.1 channels with an arginine residue in the HB helix substituted for its equivalent lysine residue in the K 2.2a channels (R355K). K 2.1 channels harbouring a three-amino-acid insertion upstream of the cognate R438 residues in the HB helix showed no response to CyPPA, whereas the deletion mutant (K 2.1_ΔA434/Q435/K436) became sensitive to CyPPA. In molecular dynamics simulations, CyPPA docked between calmodulin C-lobe and the HA/HB helices widens the cytoplasmic gate of K 2.2a channels.
Selectivity of CyPPA among K 2 and K 3.1 channel subtypes relies on the HA/HB helices.
在小电导钙激活钾(K 2 )通道的激活状态下,钙调蛋白与 HA/HB 螺旋和 S4-S5 连接子相互作用。CyPPA 增强 K 2.2a 和 K 2.3 通道的活性,但不增强 K 2.1 和 K 3.1 亚型。
利用定点突变、膜片钳记录和计算机建模来探讨 CyPPA 对 K 2 通道亚型选择性调节的结构决定因素。
将 K 2.2a 通道的 HA(V420)和 HB(K467)螺旋中的残基突变为 K 3.1 通道中的等效残基,降低了 CyPPA 的效力。CyPPA 在突变的 K 3.1 通道上引起明显的反应,其 HB 螺旋中的精氨酸取代了 K 2.2a 通道中相应的赖氨酸(R355K)。在 HB 螺旋中,K 2.1 通道上游的三个氨基酸插入使 R438 残基失去了对 CyPPA 的反应,而缺失突变体(K 2.1_ΔA434/Q435/K436)对 CyPPA 变得敏感。在分子动力学模拟中,CyPPA 在钙调蛋白 C 结构域和 HA/HB 螺旋之间结合,使 K 2.2a 通道的细胞质门变宽。
CyPPA 在 K 2 和 K 3.1 通道亚型之间的选择性依赖于 HA/HB 螺旋。